PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16731829-8 2006 Pioglitazone suppressed high glucose-induced phosphorylation of p44/42 mitogen-activated protein kinase and reduced Bcl-2 and p27(Kip1) protein levels. Pioglitazone 0-12 BCL2 apoptosis regulator Homo sapiens 116-121 17267584-6 2007 Pioglitazone (100 microM) induced apoptosis in human VSMC from diabetic and nondiabetic patients (NDP), analyzed by DNA fragmentation and by degradation of Bcl-2, in high-glucose-containing medium (15 and 25 mM). Pioglitazone 0-12 BCL2 apoptosis regulator Homo sapiens 156-161 16520894-5 2006 In addition, pioglitazone caused a down-regulation of the X chromosome-linked inhibitor of apoptosis (XIAP), Bcl-2, and cyclooxygenase-2 (COX-2) under conditions leading to PPARgamma down-regulation. Pioglitazone 13-25 BCL2 apoptosis regulator Homo sapiens 109-114 16520894-6 2006 These results suggest that pioglitazone may have therapeutic relevance or significance in the treatment of human CRC, and the down-regulation of XIAP, Bcl-2, and COX-2 may contribute to pioglitazone-induced apoptosis in these and other RB-deficient cell lines and tumors. Pioglitazone 186-198 BCL2 apoptosis regulator Homo sapiens 151-156 15094967-6 2004 Pretreatment of cells with the PPAR-gamma ligand pioglitazone blocked TNF-alpha-mediated apoptosis, caspase-3 activation, expression of Bcl-2, and lipid peroxidation (P <.01 vs TNF-alpha alone). Pioglitazone 49-61 BCL2 apoptosis regulator Homo sapiens 136-141 15094967-8 2004 The PPAR-gamma ligand pioglitazone modulates lipid peroxidation, alters Bcl-2 expression and caspase-3 activation, and finally reduces apoptosis. Pioglitazone 22-34 BCL2 apoptosis regulator Homo sapiens 72-77 14686729-11 2003 Furthermore, treatment of fresh glioblastoma tissue from patients with PGZ, either alone or in combination with ATRA, induced a significant level of tumor cell apoptosis together with a downregulation of bcl-2 protein level as compared with untreated control brain tissue. Pioglitazone 71-74 BCL2 apoptosis regulator Homo sapiens 204-209 34466155-0 2021 Pioglitazone mediates apoptosis in Caki cells via downregulating c-FLIP(L) expression and reducing Bcl-2 protein stability. Pioglitazone 0-12 BCL2 apoptosis regulator Homo sapiens 99-104 34466155-7 2021 The protein expression levels of cellular FLICE (FADD-like IL-1beta-converting enzyme)-inhibitory protein (c-FLIP)(L) and Bcl-2, which were determined by western blotting, decreased after pioglitazone treatment in Caki cells. Pioglitazone 188-200 BCL2 apoptosis regulator Homo sapiens 122-127 34466155-10 2021 Of note, it was found by western blot analysis that Bcl-2 protein expression was downregulated by the decreased protein stability of Bcl-2 in pioglitazone-treated Caki cells. Pioglitazone 142-154 BCL2 apoptosis regulator Homo sapiens 52-57 34466155-10 2021 Of note, it was found by western blot analysis that Bcl-2 protein expression was downregulated by the decreased protein stability of Bcl-2 in pioglitazone-treated Caki cells. Pioglitazone 142-154 BCL2 apoptosis regulator Homo sapiens 133-138 34466155-11 2021 In conclusion, these findings indicated that pioglitazone-induced apoptosis is regulated through caspase-mediated degradation of FLIP(L) and reduction of Bcl-2 protein stability, suggesting that pioglitazone is a feasible apoptotic agent that could be used in the treatment of human RC. Pioglitazone 45-57 BCL2 apoptosis regulator Homo sapiens 154-159 34466155-11 2021 In conclusion, these findings indicated that pioglitazone-induced apoptosis is regulated through caspase-mediated degradation of FLIP(L) and reduction of Bcl-2 protein stability, suggesting that pioglitazone is a feasible apoptotic agent that could be used in the treatment of human RC. Pioglitazone 195-207 BCL2 apoptosis regulator Homo sapiens 154-159 32881246-6 2020 Pioglitazone treatment significantly increased cell viability, promoted SIRT1-p53 interaction, upregulated Bcl-2 expression, activated SIRT1 and elevated mitochondrial ATP synthesis after cisplatin treatment. Pioglitazone 0-12 BCL2 apoptosis regulator Homo sapiens 107-112 14686729-9 2003 In addition, apoptosis occurred in both cell lines treated with either PGZ or ATRA, which was associated with a downregulation of bcl-2 and an upregulation of bax proteins. Pioglitazone 71-74 BCL2 apoptosis regulator Homo sapiens 130-135 32881246-8 2020 Pioglitazone also reduced the activation of caspase-3 and caspase-9, lowered the ratio of Bax/Bcl-2, attenuated kidney pathological damage and dysfunction, down-regulated the expression of Acetyl-p53, PUMA-alpha and Bax and abated cell apoptosis after cisplatin treatment. Pioglitazone 0-12 BCL2 apoptosis regulator Homo sapiens 94-99